相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
Marieke Vermeersch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Structure-Activity Study of Pentamidine Analogues as Antiprotozoal Agents
Svetlana M. Bakunova et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Paromomycin: Uptake and resistance in Leishmania donovani
Anupam Jhingran et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen
Elizabeth R. Sharlow et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials
Nashira Campos Vieira et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Risk factors of visceral leishmaniasis in East Africa: a case-control study in Pokot territory of Kenya and Uganda
Jan H. Kolaczinski et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
Asymmetries of Poverty: Why Global Burden of Disease Valuations Underestimate the Burden of Neglected Tropical Diseases
Charles H. King et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
Francois Chappuis et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
Characterization of orphan human cytochromes P450
Katarina Stark et al.
DRUG METABOLISM REVIEWS (2007)
Advances and perspectives in Leishmania cell based drug-screening procedures
D. Sereno et al.
PARASITOLOGY INTERNATIONAL (2007)
Innovative lead discovery strategies for tropical diseases
Solomon Nwaka et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Novel compounds active against Leishmania major
S St George et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Preclinical pharmacokinetics: An approach towards safer and efficacious drugs
SS Singh
CURRENT DRUG METABOLISM (2006)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
The genome of the kinetoplastid parasite, Leishmania major
AC Ivens et al.
SCIENCE (2005)
Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium
TS Tiuman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Drugs against leishmaniasis: a synergy of technology and partnerships
AJ Davis et al.
TRENDS IN PARASITOLOGY (2004)
Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages
M Junghae et al.
INFECTION AND IMMUNITY (2002)
Confirmation of primary active substances from high throughput screening of chemical and biological populations: A statistical approach and practical considerations
JH Zhang et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2000)
分享论文
